Home » Topics » Regulatory » Patents

Patents
RSS

Gilead Sciences synthesizes novel compounds for hepatitis C

Dec. 30, 2011

Novel MOMP-based products claimed at University of Surrey

Dec. 30, 2011

Collaborating Japanese companies present new antioxidants

Dec. 30, 2011

Merck & Co. patents new soluble guanylate cyclase activators

Dec. 30, 2011

Avidin discloses novel matrix metalloproteinase inhibitors

Dec. 30, 2011

New peptides with anxiolytic activity designed in Japan

Dec. 30, 2011

Prosidion claims novel GPR119 receptor agonists/DPP IV inhibitors

Dec. 29, 2011

New antimicrobial peptides designed in Germany

Dec. 29, 2011

New sigma non-opioid intracellular receptor 1 ligands patented

Dec. 29, 2011

Aska Pharmaceutical discloses novel histamine H1 receptor antagonists

Dec. 29, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...